DXCM vs. LH: DexCom vs. Labcorp Stock Comparison
How do DexCom (DXCM) and Labcorp (LH) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
DexCom (DXCM) and Labcorp (LH) both fall under the Health Care Equipment & Services industry group, but DXCM is classified in Health Care Equipment & Supplies while LH is classified in Health Care Providers & Services.
| Profile Item | DXCM | LH |
|---|---|---|
| Name | DexCom Inc. | Labcorp Holdings Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Services |
| Market Capitalization | 29.62 billion USD | 29.77 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | April 14, 2005 | March 29, 1990 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DXCM | LH |
|---|---|---|
| Total Return (1Y) | 46.33% | 48.62% |
| Total Return (3Y, Annualized) | -4.50% | 23.39% |
| Total Return (5Y, Annualized) | -12.76% | 10.54% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | DXCM | LH |
|---|---|---|
| Volatility (1Y, Annualized) | 38.37% | 24.36% |
| Beta (5Y) | 1.43 | 0.85 |
| Max Drawdown (5Y) | -66.32% | -34.61% |
| Avg. Volume (3M) | 4.34M | 721.05K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DXCM | LH |
|---|---|---|
| Sharpe Ratio (1Y) | 1.10 | 1.82 |
| Sortino Ratio (1Y) | 1.79 | 2.99 |
Profitability
ROE (TTM)
DexCom (DXCM) at 37.67% sits in the top ROE quartile, while Labcorp (LH) at 11.44% is closer to the peer norm — stronger capital efficiency for DXCM.
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
LH
Health Care Equipment & Services industry group
11.44%
- Max
- 47.61%
- Q3
- 14.36%
- LH
- 11.44%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
DexCom (DXCM) at 19.42% retains a top-quartile share of revenue as profit, ahead of Labcorp (LH) at 6.88%, which keeps about the industry-typical share.
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
LH
Health Care Equipment & Services industry group
6.88%
- Max
- 29.35%
- Q3
- 9.33%
- LH
- 6.88%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
DexCom (DXCM) at 24.34% operates in the top operating margin quartile, ahead of Labcorp (LH) at 10.91%, which runs around its industry’s norm.
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
LH
Health Care Equipment & Services industry group
10.91%
- Max
- 35.43%
- Q3
- 14.14%
- LH
- 10.91%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DXCM | LH |
|---|---|---|
| ROE (TTM) | 37.67% | 11.44% |
| ROA (TTM) | 11.14% | 5.48% |
| Net Margin (TTM) | 19.42% | 6.88% |
| Operating Margin (TTM) | 24.34% | 10.91% |
| Gross Margin (TTM) | 63.42% | 28.96% |
Growth
Revenue Growth
Both DexCom (DXCM) at 15.60% and Labcorp (LH) at 7.25% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
DexCom (DXCM) at 47.18% sits in the top EPS growth quartile, while Labcorp (LH) at 18.33% is closer to the peer norm — faster per-share earnings growth for DXCM.
Growth Metrics
| Metric | DXCM | LH |
|---|---|---|
| Revenue Growth (YoY) | 15.60% | 7.25% |
| Revenue Growth (3Y CAGR) | 17.01% | 5.55% |
| EPS Growth (YoY) | 47.18% | 18.33% |
| EPS Growth (3Y CAGR) | 36.60% | -9.19% |
Financial Strength
Current Ratio (MRQ)
Both DexCom (DXCM) at 1.74 and Labcorp (LH) at 1.41 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
LH
Health Care Equipment & Services industry group
1.41
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- LH
- 1.41
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both DexCom (DXCM) at 0.55 and Labcorp (LH) at 0.77 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
LH
Health Care Equipment & Services industry group
0.77
- Max
- 1.88
- Q3
- 0.91
- LH
- 0.77
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | DXCM | LH |
|---|---|---|
| Current Ratio (MRQ) | 1.74 | 1.41 |
| Debt / Equity (MRQ) | 0.55 | 0.77 |
| Net Debt / EBITDA | -0.28 | 2.81 |
Dividends
Dividend Yield (TTM)
DexCom (DXCM) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Labcorp (LH) reports a yield of 0.79%, ranking against industry peers normally.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LH
Health Care Equipment & Services industry group
0.79%
- LH
- 0.79%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
DexCom (DXCM) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Labcorp (LH) reports a payout of 23.61%, ranking against industry peers normally.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LH
Health Care Equipment & Services industry group
23.61%
- LH
- 23.61%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DXCM | LH |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.79% |
| Dividend Payout Ratio (TTM) | 0.00% | 23.61% |
Valuation
P/E Ratio (TTM)
Both DexCom (DXCM) at 31.26 and Labcorp (LH) at 30.05 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
LH
Health Care Equipment & Services industry group
30.05
- Max
- 80.41
- Q3
- 47.62
- LH
- 30.05
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Labcorp (LH) at 2.04 is priced about in line with its industry on P/S ratio, while DexCom (DXCM) at 5.80 sits in the pricier quartile — DXCM costs more per dollar of sales.
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
LH
Health Care Equipment & Services industry group
2.04
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- LH
- 2.04
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Labcorp (LH) at 3.36 is valued about in line with its industry on P/B ratio, while DexCom (DXCM) at 11.68 carries an above-peer premium to book — DXCM is pricier on assets.
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
LH
Health Care Equipment & Services industry group
3.36
- Max
- 11.68
- Q3
- 6.12
- LH
- 3.36
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DXCM | LH |
|---|---|---|
| P/E Ratio (TTM) | 31.26 | 30.05 |
| P/S Ratio (TTM) | 5.80 | 2.04 |
| P/B Ratio (MRQ) | 11.68 | 3.36 |
| Free Cash Flow Yield (TTM) | 2.74% | 3.55% |